These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 26264553

  • 1. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH, Hu TH, Lu SN, Kuo FY, Chen CH, Wang JH, Huang CM, Lee CM, Lin CY, Yen YH, Chiu YC.
    Int J Cancer; 2016 Feb 01; 138(3):714-20. PubMed ID: 26264553
    [Abstract] [Full Text] [Related]

  • 2. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep 01; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 3. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y, Gao Y, Shi W, Zhai D, Rao Q, Jia X, Liu J, Jiao X, Du Z.
    Cancer Biomark; 2015 Sep 01; 15(2):171-80. PubMed ID: 25519019
    [Abstract] [Full Text] [Related]

  • 4. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma.
    Ghosh A, Ghosh A, Datta S, Dasgupta D, Das S, Ray S, Gupta S, Datta S, Chowdhury A, Chatterjee R, Mohapatra SK, Banerjee S.
    Int J Cancer; 2016 Jun 01; 138(11):2732-44. PubMed ID: 26756996
    [Abstract] [Full Text] [Related]

  • 5. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE, Fawzy NA, El-Sheikh SM, Soliman ME.
    Mol Diagn Ther; 2015 Aug 01; 19(4):213-20. PubMed ID: 26133725
    [Abstract] [Full Text] [Related]

  • 6. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F, Lu Z, Chen B, Dong P, Zheng J.
    Diagn Pathol; 2015 Jul 28; 10():129. PubMed ID: 26215970
    [Abstract] [Full Text] [Related]

  • 7. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ, Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, Jia WH, Jie Y, Chen MS, Chen MX, Fang JH, Zeng C, Zhang Y, Guo RP, Wu Y, Lin G, Zheng L, Zhuang SM.
    Lancet Oncol; 2015 Jul 28; 16(7):804-15. PubMed ID: 26088272
    [Abstract] [Full Text] [Related]

  • 8. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS, Elgendy NA, Tawfik NA, Elnasser AM.
    Egypt J Immunol; 2019 Jul 28; 26(2):31-40. PubMed ID: 31926493
    [Abstract] [Full Text] [Related]

  • 9. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y, Zhang N, Guo H.
    Tumour Biol; 2016 May 28; 37(5):6539-49. PubMed ID: 26637228
    [Abstract] [Full Text] [Related]

  • 10. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N, Duong DC, Tong HV, Hien TTT, Hoan PQ, Bang MH, Binh MT, Ky TD, Tung NL, Thinh NT, Sang VV, Thao LTP, Bock CT, Velavan TP, Meyer CG, Song LH, Toan NL.
    PLoS One; 2018 May 28; 13(4):e0196081. PubMed ID: 29672637
    [Abstract] [Full Text] [Related]

  • 11. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L, Lu B, Yu J, Liu W, Zhou A.
    Clin Res Hepatol Gastroenterol; 2016 Sep 28; 40(4):397-404. PubMed ID: 26724963
    [Abstract] [Full Text] [Related]

  • 12. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
    Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K.
    Cancer Res; 2010 Dec 01; 70(23):9798-807. PubMed ID: 21098710
    [Abstract] [Full Text] [Related]

  • 13. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma.
    Zhou J, Yu L, Gao X, Hu J, Wang J, Dai Z, Wang JF, Zhang Z, Lu S, Huang X, Wang Z, Qiu S, Wang X, Yang G, Sun H, Tang Z, Wu Y, Zhu H, Fan J.
    J Clin Oncol; 2011 Dec 20; 29(36):4781-8. PubMed ID: 22105822
    [Abstract] [Full Text] [Related]

  • 14. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM.
    Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):555-562. PubMed ID: 32102538
    [Abstract] [Full Text] [Related]

  • 15. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y, Han J, Chen J, Dong J, Xia Y, Liu J, Jiang Y, Dai J, Lu J, Jin G, Han J, Wei Q, Shen H, Sun B, Hu Z.
    Int J Cancer; 2015 Oct 01; 137(7):1679-90. PubMed ID: 25845839
    [Abstract] [Full Text] [Related]

  • 16. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT, Liu RB, Liang YY, Hasan AME, Wang HY, Shao Q, Zhang ZC, Wang J, He CY, Wang F, Shao JY.
    Liver Int; 2017 Jun 01; 37(6):888-896. PubMed ID: 28061012
    [Abstract] [Full Text] [Related]

  • 17. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X, Zhang J, Zhou L, Lu P, Zheng ZG, Sun W, Wang JL, Yang XS, Li XL, Xia N, Zhang N, Dou KF.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(2):1466-78. PubMed ID: 25973032
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus.
    Tan Y, Lin B, Ye Y, Wen D, Chen L, Zhou X.
    Oncol Rep; 2015 Jun 01; 33(6):2863-70. PubMed ID: 25962820
    [Abstract] [Full Text] [Related]

  • 19. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma.
    Zhuang C, Jiang W, Huang D, Xu L, Yang Q, Zheng L, Wang X, Hu L.
    Clin Res Hepatol Gastroenterol; 2016 Sep 01; 40(4):386-96. PubMed ID: 26669589
    [Abstract] [Full Text] [Related]

  • 20. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.